Choosing a risk-based health care contract felt more like picking among a series of mystery flavors at an ice cream shop, Syntax CEO Rachael Jones learned after 25 years in the business — so she started a company to melt away the opacity.
Why it matters: Syntax raised $7.5 million in seed funding to launch publicly on Thursday, Jones tells Axios exclusively.
